This Biotech Stock Winner Is Up 72%, but a $4 Million Trim Signals a Slight Reset

DAFNA Capital Management sold 222,847 SNDX shares in the fourth quarter for an estimated roughly $4 million. Meanwhile, the quarter-end position value decreased by $1.87 million, reflecting both trading and price movements.